Strategy for Developing a Stable CHO Cell Line that Produces Large Titers of Trastuzumab Antibody
{{output}}
Background: Trastuzumab (Herceptin®) is currently the main treatment option for breast cancer patients that overexpress the human epidermal growth factor receptor 2 (HER2). This antibody binds specifically to HER2, blocks cancer... ...
